2026-10-27 · 1 篇
人工智能、多组学与多模态整合在头颈癌精准放疗中的应用：从生物学洞见到治疗决策
Artificial Intelligence, Multi-Omics, and Multimodal Integration in Precision Radiotherapy for Head and Neck Cancer: From Biological Insights to Treatment Decisions.
2026-10-25 · 1 篇
中国HBV相关肝细胞癌与EBV相关鼻咽癌的免疫药理学进展：机制、治疗与临床展望
Immunopharmacological Advances in HBV Associated Hepatocellular Carcinoma and EBV-Related Nasopharyngeal Carcinoma in China: Mechanisms, Therapies, and Clinical Perspectives.
2026-10-16 · 1 篇
生长抑素受体在非神经内分泌肿瘤中的表达及诊疗一体化应用：从分子到临床的综述
Somatostatin Receptor Expression and Theranostic Applications Across Non-Neuroendocrine Tumors: A Molecular-to-Clinical Review.
2026-10-15 · 1 篇
循环游离EB病毒DNA检测用于鼻咽癌：迈向ctDNA指导的风险适应性个体化治疗
Circulating cell-free Epstein-Barr virus DNA measurement for nasopharyngeal carcinoma: advancing towards ctDNA-guided, risk-adaptive individualized treatment.
2026-10-14 · 2 篇
血清尿酸与鼻咽癌预后之间的关联：一项观察性研究的综合荟萃分析
The association between serum uric acid and prognosis of nasopharyngeal carcinoma: a comprehensive meta-analysis of observational studies.
中性粒细胞与淋巴细胞比值在鼻咽癌中的预后价值：截至2026年6月30日30个队列的系统评价与荟萃分析。
Prognostic value of neutrophil-to-lymphocyte ratio in nasopharyngeal carcinoma: a systematic review and meta-analysis of 30 cohorts through June 30, 2026.
2026-10-09 · 1 篇
免疫治疗时代转移性鼻咽癌的系统治疗：一篇批判性综述。
Systemic therapy for metastatic nasopharyngeal carcinoma in the immunotherapy era: A critical review.
2026-10-04 · 1 篇
癌症中的双特异性抗体-药物偶联物：治疗窗决定因素、肿瘤-免疫相互作用及临床转化
Bispecific antibody-drug conjugates in cancer: therapeutic-window determinants, tumour-immune interactions, and clinical translation.
2026-10-01 · 1 篇
欧洲和北美儿童及青少年中EBV归因性癌症：一项荟萃分析
Epstein-Barr virus-attributable cancers among children and adolescents in Europe and North America: a meta-analysis.
2026-09-30 · 1 篇
PD-1/PD-L1抑制剂联合抗血管生成酪氨酸激酶抑制剂治疗复发或转移性鼻咽癌的疗效与安全性：系统评价与单臂荟萃分析
Efficacy and Safety of PD-1/PD-L1 Inhibitors Combined With Anti-Angiogenic Tyrosine Kinase Inhibitors for Recurrent or Metastatic Nasopharyngeal Carcinoma: A Systematic Review and Single-Arm Meta-Analysis.
2026-09-26 · 1 篇
EB病毒相关鼻咽癌中HMGB1的翻译后修饰：当前证据、新兴机制概念及未解决问题
HMGB1 Post-Translational Modifications in Epstein-Barr Virus-Associated Nasopharyngeal Carcinoma: Current Evidence, Emerging Mechanistic Concepts, and Unresolved Questions.
2026-09-17 · 2 篇
放射性颞叶损伤破坏神经-免疫交互：局部晚期鼻咽癌免疫功能障碍的关键驱动因素。
Radiation-induced temporal lobe injury disrupts neuro-immune crosstalk: A key driver of immune dysfunction in locally advanced nasopharyngeal carcinoma.
鼻咽癌：流行病学、危险因素、信号通路、临床特征、诊断与治疗
Nasopharyngeal carcinoma: epidemiology, risk factors, signaling pathways, clinical features, diagnosis, and management.
2026-09-16 · 3 篇
派安普利单抗：一种用于癌症免疫治疗的下一代Fc工程化PD-1抑制剂。
Penpulimab: A next-generation Fc-engineered PD-1 inhibitor in cancer immunotherapy.
尼妥珠单抗联合放化疗治疗头颈部鳞状细胞癌和鼻咽癌：系统评价与荟萃分析。
Nimotuzumab Combined With Chemoradiotherapy in Head and Neck Squamous Cell Carcinoma and Nasopharyngeal Carcinoma: A Systematic Review and Meta-Analysis.
鼻咽癌监测策略的最新进展
Recent Advances in Surveillance Strategies for Nasopharyngeal Carcinoma.